Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT ID: NCT00780507
Last Updated: 2013-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2007-08-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hematological Indices and Fecal Calprotectin Predict Histological Remission in Ulcerative Colitis
NCT04818788
A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis
NCT03698812
A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination
NCT04849936
Microbial and Human Determinants of the Onset of IBD Flares
NCT05463900
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients are in a state of remission
No interventions assigned to this group
2
Patients are in a flare
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be enrolled in Study 2007021 (QDIEM).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Warner Chilcott
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William S Aronstein, MD, PhD
Role: STUDY_DIRECTOR
Procter and Gamble
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Facility
Lowell, Arkansas, United States
Research Facility
Anaheim, California, United States
Research Facility
Folsom, California, United States
Research Facility
Los Angeles, California, United States
Research Facility
Merced, California, United States
Research Facility
San Diego, California, United States
Research Facility
Upland, California, United States
Research Facility
Lafayette, Colorado, United States
Research Facility
Torrington, Connecticut, United States
Research Facility
Fort Lauderdale, Florida, United States
Research Facility
New Port Richey, Florida, United States
Research Facility
Palm Harbor, Florida, United States
Research Facility
Tampa, Florida, United States
Research Facility
Zephyrhills, Florida, United States
Research Facility
Decatur, Georgia, United States
Research Facility
Marietta, Georgia, United States
Research Facility
Newnan, Georgia, United States
Research Facility
Arlington Heights, Illinois, United States
Research Facility
Oak Lawn, Illinois, United States
Research Facility
Urbana, Illinois, United States
Research Facility
South Bend, Indiana, United States
Research Facility
Clive, Iowa, United States
Research Facility
Topeka, Kansas, United States
Research Facility
Bowling Green, Kentucky, United States
Research Facility
Shreveport, Louisiana, United States
Research Facility
Lutherville, Maryland, United States
Research Facility
Braintree, Massachusetts, United States
Research Facility
Chesterfield, Michigan, United States
Research Facility
Rochester Hills, Michigan, United States
Research Facility
Jefferson City, Missouri, United States
Research Facility
Egg Harbor, New Jersey, United States
Research Facility
Babylon, New York, United States
Research Facility
Binghamton, New York, United States
Research Facility
Cheektowaga, New York, United States
Research Facility
Forest Hills, New York, United States
Research Facility
Lake Success, New York, United States
Research Facility
Pittsford, New York, United States
Research Facility
Port Jefferson Station, New York, United States
Research Facility
Boone, North Carolina, United States
Research Facility
Morganton, North Carolina, United States
Research Facility
New Bern, North Carolina, United States
Research Facility
Raleigh, North Carolina, United States
Research Facility
Canton, Ohio, United States
Research Facility
Cincinnati, Ohio, United States
Research Facility
Cincinnati, Ohio, United States
Research Facility
Indiana, Pennsylvania, United States
Research Facility
Lancaster, Pennsylvania, United States
Research Facility
Warwick, Rhode Island, United States
Research Facility
Jackson, Tennessee, United States
Research Facility
Greenville, Texas, United States
Research Facility
Houston, Texas, United States
Research Facility
Houston, Texas, United States
Research Facility
Lewisville, Texas, United States
Research Facility
Longview, Texas, United States
Research Facility
Odessa, Texas, United States
Research Facility
Pasadena, Texas, United States
Research Facility
Plano, Texas, United States
Research Facility
Alexandria, Virginia, United States
Research Facility
Chesapeake, Virginia, United States
Research Facility
Winchester, Virginia, United States
Research Facility
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.